Related Experiment Video
Updated: Aug 14, 2026

Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
[Endogenous cannabinoid system. Effect on neuronal plasticity and pain memory]
1Abt. Klinische Neuropharmakologie, Max-Planck-Institut für Psychiatrie München. azad@mpipsykl.mpg.de
Aim:
The aim of this study was to evaluate the role of the endogenous cannabinoid system in controlling neuroplasticity.
Methods:
The pain threshold for electrical stimuli was determined in transgenic mice lacking the cannabinoid receptor type 1 (CB1(-/-)) and in the corresponding respective wild-type animals. Electrophysiological experiments were performed in prepared brain slices to test the effect of endogenous and exogenous cannabinoids on synaptic transmission and long-term potentiation (LTP) in the amygdala.
Results:
The pain threshold was nearly identical in both groups for the first pain induction; however, with repeated pain induction it decreased to a significantly greater extent in the CB1(-/-) mice than in the wild-type animals. Synoptic transmission and the inducibility of LTP were not influenced by the acute pharmacological blockade of CB1 receptors, but inhibited by the CB1 agonist WIN55,212-2.
Conclusion:
The endogenous cannabinoid system is involved in the control of neuroplasticity as part of pain processing . Cannabinoids prevent the formation of LTP in the amygdala via activation of CB1 receptors. Synoptic transmission and the inducibility of LTP were not influenced by the acute pharmacological blockade of CB1 receptors, but inhibited by the CB1 agonist Win55,212-2.
Insights
The endogenous cannabinoid system, via cannabinoid receptor type 1 (CB1), influences neuroplasticity and pain processing. Cannabinoids inhibit long-term potentiation (LTP) in the amygdala, impacting pain perception.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Context:
- The endogenous cannabinoid system plays a crucial role in regulating physiological processes.
- Neuroplasticity, particularly in the context of pain, is a complex phenomenon influenced by various signaling pathways.
- Cannabinoid receptor type 1 (CB1) is a key component of the endocannabinoid system, implicated in pain modulation.
Purpose:
- To investigate the role of the endogenous cannabinoid system in controlling neuroplasticity.
- To determine the impact of cannabinoid receptor type 1 (CB1) on pain processing and synaptic plasticity.
- To evaluate the effects of endogenous and exogenous cannabinoids on synaptic transmission and long-term potentiation (LTP) in the amygdala.
Summary:
- Transgenic mice lacking CB1 receptors exhibited a greater decrease in pain threshold with repeated pain induction compared to wild-type animals.
- Electrophysiological experiments showed that while acute blockade of CB1 receptors did not affect synaptic transmission or LTP, activation of CB1 receptors by an agonist inhibited LTP in the amygdala.
- These findings indicate that the endogenous cannabinoid system, through CB1 receptor activation, is involved in modulating neuroplasticity during pain processing.
Impact:
- This research elucidates the specific mechanisms by which the endocannabinoid system regulates neuroplasticity in pain pathways.
- Understanding the role of CB1 receptors in LTP inhibition offers potential therapeutic targets for pain management.
- The study highlights the differential effects of CB1 receptor blockade versus activation on synaptic function and pain perception.
Related Concept Videos
Analgesia and Pain Management
Nociception
Pain
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Neuroplasticity
Long-term Potentiation
